Shopping Cart
Remove All
Your shopping cart is currently empty
SBI-581 is an orally active, potent selective inhibitor of serine-threonine kinase TAO3, with an IC 50 of 42 nM. It effectively promotes the accumulation of TKS5α at RAB11-positive vesicles and inhibits the formation of invadopodia. Additionally, SBI-581 exhibits reasonable pharmacokinetics in mice when administered via IP injection, demonstrating significant antitumor activity [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,450 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,320 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,730 | 10-14 weeks | 10-14 weeks |
| Description | SBI-581 is an orally active, potent selective inhibitor of serine-threonine kinase TAO3, with an IC 50 of 42 nM. It effectively promotes the accumulation of TKS5α at RAB11-positive vesicles and inhibits the formation of invadopodia. Additionally, SBI-581 exhibits reasonable pharmacokinetics in mice when administered via IP injection, demonstrating significant antitumor activity [1]. |
| In vitro | SBI-581 exhibits moderate selectivity, surpassing the majority of a wide array of kinases by a factor of 5 to 10 times [1]. |
| In vivo | SBI-581, administered intraperitoneally at a dosage of 10 mg/kg, demonstrates favorable pharmacokinetics, characterized by a half-life (t 1/2) of 1.5 hours, an area under the curve (AUC) of 1202 hr*ng/mL, and a maximum concentration (Cmax) of approximately 2 μM [1]. |
| Molecular Weight | 383.44 |
| Formula | C24H21N3O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.